Please assess the completion status of the following clinical trial:

Trial Title: A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women 45-60 years of age;~* post-menopausal;~* ambulatory.~Exclusion Criteria:~* vertebral fracture (except traumatic fracture such as in a motor vehicle accident);~* low-trauma osteoporotic fracture in any other bone;~* breast cancer diagnosed within last 20 years;~* other malignancy diagnosed within last 10 years, except successfully resected basal cell cancer;~* treatment with any bisphosphonate within last 2 years;~* treatment with other drugs affecting bone metabolism within last 6 months.

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).